A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease; SERENITY

Press/Media: Press / Media

PeriodOct 2 2018

Media coverage

1

Media coverage

  • TitleA Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease; SERENITY
    Media name/outletClinical Trials.gov
    CountryUnited States
    Date10/2/18
    PersonsThomas J McDonald